Skip to main content
Berry Genomics Co.,Ltd logo

Berry Genomics Co.,Ltd — Investor Relations & Filings

Ticker · 000710 ISIN · CNE000000PN7 Shenzhen Stock Exchange Professional, scientific and technical activities
Open in API
Filings indexed 2,009 across all filing types
Latest filing 2025-04-24 Audit Report / Informat…
Country CN China
Listing Shenzhen Stock Exchange 000710

About Berry Genomics Co.,Ltd

https://www.berrygenomics.com

Berry Genomics Co.,Ltd. is a biotechnology enterprise specializing in clinical genomics and genetic testing services. The company focuses on the research, development, and commercialization of genomic technologies for clinical applications. Its core portfolio includes non-invasive prenatal testing (NIPT), utilizing high-throughput sequencing to screen for chromosomal abnormalities. Beyond reproductive health, the company provides genomic solutions for oncology diagnostics, including early cancer screening and companion diagnostics, as well as testing for hereditary diseases. Berry Genomics leverages advanced sequencing platforms and proprietary bioinformatics pipelines to deliver precision medicine tools to healthcare providers and research institutions. The company is recognized for its role in the clinical application of Next-Generation Sequencing (NGS) and its extensive genomic databases used to enhance diagnostic accuracy and therapeutic outcomes.

Recent filings

Filing Released Lang Actions
2024年度营业收入扣除事项的专项核查报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report titled '2024年度营业收入扣除事项的专项核查报告' (Special Audit Report on Revenue Deduction Items for 2024) issued by an accounting firm. It includes the auditor's responsibilities, management's responsibilities, and a detailed table of revenue deductions for the fiscal year 2024. The report is not a full annual report but a standalone audit-related document focusing on specific revenue deduction verification. It contains substantive financial data and audit opinions, indicating it is an audit report rather than a general annual report or a simple announcement. The document length is 2855 characters, which is relatively short but contains detailed audit content, not just a publication announcement or certification. Therefore, the appropriate classification is Audit Report / Information (AR). FY 2024
2025-04-24 Chinese
关于聘请2025年度审计机构的公告
Audit Report / Information Classification · 95% confidence The document is an announcement regarding the appointment of the audit firm for the 2025 fiscal year. It details the selection process, qualifications of the audit firm, and approvals by the board and supervisory committee. It does not contain any financial statements or audit results, but rather is a formal notice about the hiring of the auditor. The document length is under 5,000 characters and it is clearly an announcement, not the audit report itself. Therefore, it fits best under the category of Audit Report / Information announcements, specifically the announcement of the appointment of the audit firm, which aligns with the Audit Report / Information (AR) category rather than the full audit report or annual report. FY 2025
2025-04-24 Chinese
年度关联方资金占用专项审计报告
Audit Report / Information Classification · 95% confidence The document is a specialized audit report on non-operating fund occupation and other related party fund transactions for the year 2024 of Chengdu Berry Genomics Co., Ltd. It includes an auditor's opinion, references to Chinese auditing standards, and detailed financial data related to fund occupation and related party transactions. The document is not a full annual report but a standalone audit report focusing on a specific financial aspect, consistent with the definition of an Audit Report / Information (AR). The length (7309 characters) and content indicate it is the report itself, not just an announcement or certification. Therefore, the appropriate classification is AR. FY 2024
2025-04-24 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement regarding a change in accounting policies by the company 成都市贝瑞和康基因技术股份有限公司. It details the reasons for the change, references specific accounting standards and regulations issued by the Ministry of Finance of China, and states that the change will not materially affect the company's financials. The document is relatively short (1312 characters) and does not contain actual financial statements or detailed financial data. It is an announcement of a policy change rather than a full financial report or audit report. Therefore, it fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous regulatory announcements that do not fit other specific categories.
2025-04-24 Chinese
监事会决议公告
Regulatory Filings Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of the company regarding the approval of various reports and proposals related to the 2024 fiscal year, including the 2024 Annual Report, financial statements, internal control evaluation, audit firm appointment, profit distribution plan, asset impairment provision, and supervisory board remuneration. It is a formal announcement of meeting decisions and approvals, not the full annual report itself. The document is relatively short (1750 characters) and serves as a notice of resolutions passed, which will be submitted to the shareholders' meeting for further approval. Therefore, it fits best into the category of Regulatory Filings (RNS) as it is a formal regulatory announcement of board resolutions rather than the full Annual Report (10-K) or other detailed reports.
2025-04-24 Chinese
董事会对独立董事独立性评估的专项意见
Board/Management Information Classification · 95% confidence The document is a statement from the board of directors assessing the independence of the company's independent directors, referencing regulatory requirements from the China Securities Regulatory Commission and Shenzhen Stock Exchange listing rules. It is a formal opinion on director independence rather than a financial report, meeting notice, or voting result. The content fits best under Board/Management Information (MANG) as it relates to board governance and director status. The document is short and does not contain financial data or meeting materials, so it is not an Annual Report or AGM Information. Therefore, the classification is MANG with high confidence.
2025-04-24 Chinese

Browse filings by year

27 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.